Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Actavis UK Limited (Trading style: Actavis), Whiddon Valley, BARNSTAPLE, N Devon EX32 8NS
SALBUTAMOL TABLETS BP 2mg.
| Pharmaceutical Form |
|---|
|
Tablets for oral administration. |
Each tablet contains 2.4mg salbutamol sulfate equivalent to 2mg salbutamol.
Excipients with known effect:
Each 2mg tablet contains:
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Salbutamol |
Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases. |
| List of Excipients |
|---|
|
The tablets also contain: Maize starch |
Polypropylene tubes with low density polyethylene caps. Packing material: high density polyethylene film.
28s, 30s, 56s, 60s, 84s, 100s, 250s, 500s, 1000s
Polyethylene container with a polypropylene lid.
28s
Actavis UK Limited (Trading style: Actavis), Whiddon Valley, BARNSTAPLE, N Devon EX32 8NS
PL 0142/0485
Date of first authorization: 18 December 1998
Date of latest renewal: 23 October 2000
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
